Admedus Immunotherapies

Learn More Global Healthcare Company


Admedus Tissue Engineering

Learn More Healthcare Innovations - Baby Tissue Engineering


Admedus Medical Products

Learn More Hospital Equipment Australia

Welcome to Admedus

Admedus is a global healthcare company that develops, commercialises and distributes next generation medical technologies and devices. Our mission is to provide patients around the world with a better quality of life through access to our leading medical solutions and products.

Learn More

CardioCel regenerative tissue scaffold

CardioCel® is a superior cardiovascular bioscaffold used to repair and reconstruct heart defects.

Read More

Our range of medical products and devices combine quality and value with the very latest technology

View our full range of products

News & Media

< >

Admedus Wins 2016 Australian Manufacturer of the Year Award

After triumphing in the Most Innovative category, Admedus also took out the night’s biggest award ‘Manufacturer of the Year’. In August 2014 Admedus opened its state-of-the-art bio-manufacturing facility in Malaga, WA, and has experienced huge success in exporting its bio-scaffold regenerative medicine product, CardioCel, since then.

May 14th 2016

Find out more

A day with Europe’s leading cardiovascular surgeons

In April, I had the privilege of spending the day with over forty of Europe’s leading cardiovascular surgeons. The purpose – an Admedus workshop to discuss the use of CardioCel to reconstruct heart valves and its potential in the future treatment of heart valve disease. Held in Amsterdam, the experts meeting shed light on the critical issues and […]

May 5th 2016

Find out more

Are all cardiovascular tissue patches the same?

While some people may claim that all cardiovascular tissue patches (pericardial patches/bioscaffolds) are fundamentally the same, we know this is not the case. Surgeons and patients alike are searching for a bioscaffold that is safe, strong and durable. More specifically, they want a material that doesn’t calcify (harden) at the site of surgery and can […]

April 5th 2016

Find out more
The Australian Logo

Admedus HSV-2 clinical results encouraging – Morgans

Morgans healthcare analyst Scott Power talks to The Australian about Admedus’s HSV-2 Phase II clinical trial results.

March 7th 2016

Find out more
mass device logo

Admedus inks exclusive distro deal with Coroneo

Admedus (ASX:AHZ) has inked an exclusive distribution agreement with Coroneo to sell its extra aortic annuloplasty ring and other heart valve surgery instruments in Germany and the U.K.

January 27th 2016

Find out more

Upcoming Events

2016 Vascular Annual Meeting

June 8th 2016 See event details
2016 ISMICS Annual Meeting

June 15th 2016 See event details
ECHSA & CHSS 4th Joint Meeting

June 22nd 2016 See event details